Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P15
Within normal range
vs 3Y Ago
-4.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -70.66% |
| Q2 2025 | 56.42% |
| Q1 2025 | -47.94% |
| Q4 2024 | 4.84% |
| Q3 2024 | 48.67% |
| Q2 2024 | 0.73% |
| Q1 2024 | 24.62% |
| Q4 2023 | -23.07% |
| Q3 2023 | 24.91% |
| Q2 2023 | -123.06% |
| Q1 2023 | 41.80% |
| Q4 2022 | 20.71% |
| Q3 2022 | 16.23% |
| Q2 2022 | 0.98% |
| Q1 2022 | -47.85% |
| Q4 2021 | -32.86% |
| Q3 2021 | -103.00% |
| Q2 2021 | 13.14% |
| Q1 2021 | -121.61% |
| Q4 2020 | 67.79% |
| Q3 2020 | -269.45% |
| Q2 2020 | 160.39% |
| Q1 2020 | 22.18% |
| Q4 2019 | 20.81% |
| Q3 2019 | -63.32% |
| Q2 2019 | 24.75% |
| Q1 2019 | -56.53% |
| Q4 2018 | -2.71% |
| Q3 2018 | 19.96% |
| Q2 2018 | -49.43% |
| Q1 2018 | -438.18% |
| Q4 2017 | 81.25% |
| Q3 2017 | -15.92% |
| Q2 2017 | 5.09% |
| Q1 2017 | -83.90% |
| Q4 2016 | 56.28% |
| Q3 2016 | -28.39% |
| Q2 2016 | -52.45% |
| Q1 2016 | 42.33% |
| Q4 2015 | 3.39% |